PEPerchini Scientific does not display demo certificates or placeholder purity figures
We have eagerly awaited seeing the actual results since the sponsor company (Novo Nordisk) issued a press release in August that proclaimed a 20% relative reduction of cardiovascular death, heart attack or stroke, the primary endpoint of the trial
Angeli JPF, Freitas FP, Nepachalovich P, Puentes L, Zilka O, Inague A
Karam RA, Pasha, Heba F, El-Shal AS, Rahman HMA, Gad DM
In addition, it seems that ozone can be used to reduce the accumulation of FQs [13]
If you dont, youll likely continue to be plagued with recurrences